Melvin Leiner insider trades: Dna Brands (DNAB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Melvin reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 8, 2012 | DNAB | ↓ Sell | 357,637 | $0.10 | $36K | Shares are held by 4 Life LLC of which R | Oct 18, 2012 (10d) |
| Oct 8, 2012 | DNAB | ↓ Sell | 100,000 | $0.10 | $10K | 2,832,038 shares are held by 4 Life LLC | Oct 18, 2012 (10d) |
| Sep 10, 2012 | DNAB | ↓ Sell | 134,403 | $0.14 | $19K | 2,832,038 shares are held by 4 Life LLC | Oct 2, 2012 (22d) |
| Jul 12, 2012 | DNAX | ↓ Sell | 125,000 | $0.19 | $24K | 2,832,038 shares are held by 4 Life LLC, | Aug 31, 2012 (50d) |
| Jan 6, 2012 | DNAX | ↓ Sell | 28,197 | $0.46 | $13K | (1) | Apr 30, 2012 (115d) |
| Jul 29, 2011 | DNAX | ↓ Sell | 7,400 | $0.98 | $7K | (1) | Sep 1, 2011 (34d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Melvin Leiner's insider trades
Melvin Leiner is Chief Financial Officer at Dna Brands (DNAB). Since Jul 29, 2011, Melvin has reported no open-market purchases and 6 sales worth $109K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DNAB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.